Previous 10 |
There we no IPOs during the shortened holiday week. However, we expect a number of new launches in the coming week . This past week, eight IPOs joined the IPO pipeline, including four aiming to raise $100 million or more, as well as one SPAC. Thoma Bravo's software management platform Dynat...
Annovis Bio ( ANVS ) has filed a preliminary prospectus for an $11.5M IPO. More news on: Annovis Bio, Healthcare stocks news, IPO News, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Annovis announced in June 2024 that they had filed a composition of matter patent for their new crystal form of buntanetap, along with a provisional patent for the manufacturing process The company’s goal is to use this technology to restore brain function and improve the quality of life...
Annovis Bio (NYSE: ANVS) , a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today announced the receipt of U.S. Patent No. 12,042,482. The patent ...
MALVERN, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’...